Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Baron-Bodo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2017
Enhancing Allergen-Presentation Platforms for Sublingual ImmunotherapyP Moingeon, V Lombardi, V Baron-Bodo, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2012
Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapyV Baron-Bodo, T Batard, H Nguyen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 19, 2011
Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammationS Tourdot, S Airouche, N Berjont, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 23, 2011
Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⁺ T cellsM Bonvalet, E Wambre, H Moussu, et al.
Mucosal Immunology|October 13, 2016
The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammationL Mascarell, S Airouche, N Berjont, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 28, 2012
Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapyM Bonvalet, H Moussu, E Wambre, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 23, 2013
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapyV Baron-Bodo, S Horiot, A Lautrette, et al.
Allergy|September 3, 2011
Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacyL Van Overtvelt, V Baron-Bodo, S Horiot, et al.
Allergy|January 30, 2015
Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cellsL Mascarell, S Rak, M Worm, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 10, 2009
Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapyH Chabre, B Gouyon, A Huet, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2017
Enhancing Allergen-Presentation Platforms for Sublingual ImmunotherapyP Moingeon, V Lombardi, V Baron-Bodo, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2012
Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapyV Baron-Bodo, T Batard, H Nguyen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 19, 2011
Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammationS Tourdot, S Airouche, N Berjont, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 23, 2011
Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⁺ T cellsM Bonvalet, E Wambre, H Moussu, et al.
Mucosal Immunology|October 13, 2016
The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammationL Mascarell, S Airouche, N Berjont, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 28, 2012
Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapyM Bonvalet, H Moussu, E Wambre, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 23, 2013
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapyV Baron-Bodo, S Horiot, A Lautrette, et al.
Allergy|September 3, 2011
Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacyL Van Overtvelt, V Baron-Bodo, S Horiot, et al.
Allergy|January 30, 2015
Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cellsL Mascarell, S Rak, M Worm, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 10, 2009
Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapyH Chabre, B Gouyon, A Huet, et al.
Pageof 2